Methotrexate to Treat SAPHO Syndrome with Keloidal Scars

    December 2011 in “ PubMed
    Valderílio Feijó Azevedo, Vanessa Irusta Dal Pizzol, H. Lopes, Sunita Coelho, Leticia Elizabeth Augustin Czeczko Rutz
    Studysummary In this reported case of SAPHO syndrome, methotrexate treatment led to significant clinical improvement after other treatments for skin lesions and arthritis proved less effective. Our plain-language summary of this paper — not a Tressless recommendation.
    The document reported a case of a 42-year-old man with SAPHO syndrome, a rare condition characterized by skin lesions and joint issues. Initially treated for severe acne, the patient developed keloidal scars and polyarthritis over time. Despite previous treatments, significant improvement was observed after starting methotrexate at 10 mg per week, later increased to 20 mg per week, along with finasteride 5 mg per day. The case highlighted the challenges in diagnosing SAPHO syndrome and the effectiveness of methotrexate in managing symptoms, despite the progression to keloids.
    Discuss this study in the Community →